Dow Down 0.17% Nasdaq Down 0.28%

Gilead Sciences Inc. (GILD)

-NasdaqGS
106.45 Down 1.06(0.99%) 4:15PM EDT
|After Hours : 106.45 0.00 (0.00%) 4:43PM EDT
Prev Close:107.51
Open:107.40
Bid:106.25 x 100
Ask:106.62 x 300
1y Target Est:113.65
Beta:0.95
Earnings Date:Oct 28 - Oct 31 (Est.)
Day's Range:105.86 - 108.00
52wk Range:58.81 - 110.64
Volume:11,587,940
Avg Vol (3m):13,675,000
Market Cap:160.92B
P/E (ttm):24.12
EPS (ttm):4.41
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.99%160.92B
GSKDown 0.69%110.42B
PFEDown 0.67%187.50B
RHHBYUp 0.24%251.34B

Key Statistics

Forward P/E (1 yr):11.19
P/S (ttm):9.32
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.04
Quarterly EPS Est (Sep-14) :1.92
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):0.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines for the treatment of life threatening diseases in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback